Formulation Strategies to Make Intestinal Permeation Enhancers Work for Oral Peptide Drugs
Review of formulation strategies that optimize intestinal permeation enhancers for oral peptide delivery, covering how to maximize enhancer-peptide co-localization and overcome the gastrointestinal barriers that limit oral peptide absorption.
Quick Facts
What This Study Found
Formulation strategies including enteric coatings, nanoparticle co-encapsulation, mucoadhesive formulations, and timed-release systems optimize intestinal permeation enhancer efficacy for oral peptide delivery.
Key Numbers
~1% BA; FDA approvals: oral semaglutide, oral octreotide; challenges: dilution, transit, luminal interference
How They Did This
Narrative review of formulation approaches for optimizing IPE-peptide co-delivery and overcoming GI barriers.
Why This Research Matters
Oral semaglutide (Rybelsus) proved oral peptides are possible, but its bioavailability is still low (~1%). Better formulation strategies could dramatically improve oral peptide drug absorption and efficacy.
The Bigger Picture
Oral peptide delivery is transitioning from impossible to practical. Formulation science is the remaining bottleneck — turning proof-of-concept (Rybelsus) into high-bioavailability products.
What This Study Doesn't Tell Us
Review article. Most strategies preclinical. No single formulation approach solves all challenges. Patient-to-patient variability in GI conditions complicates universal formulation design.
Questions This Raises
- ?Can formulation alone increase oral peptide bioavailability from 1% to >10%?
- ?Which IPE-formulation combination shows the most promise for clinical use?
- ?Would combination formulation strategies provide additive absorption benefits?
Trust & Context
- Key Stat:
- Formulation is the bottleneck Oral peptides are possible (Rybelsus proved it) but ~1% bioavailability means 99% of the drug is wasted. Better formulations could transform this ratio
- Evidence Grade:
- Not applicable (formulation science review).
- Study Age:
- Published 2021. Oral peptide formulation continues advancing rapidly.
- Original Title:
- Formulation strategies to improve the efficacy of intestinal permeation enhancers.
- Published In:
- Advanced drug delivery reviews, 177, 113925 (2021)
- Authors:
- Maher, Sam(2), Brayden, David J(4)
- Database ID:
- RPEP-05577
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why is oral semaglutide bioavailability only ~1%?
Even with SNAC permeation enhancer, 99% of oral semaglutide is destroyed or not absorbed. The enhancer and peptide must arrive at the same gut location simultaneously, the stomach must be empty, and the absorption window is narrow. Better formulations aim to solve these challenges.
What is a permeation enhancer?
Permeation enhancers are molecules that temporarily open the tight junctions between gut lining cells, creating brief windows for peptide drugs to pass through. The challenge is getting the enhancer and drug to the same spot at the right time — which is where formulation strategy comes in.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05577APA
Maher, Sam; Brayden, David J. (2021). Formulation strategies to improve the efficacy of intestinal permeation enhancers.. Advanced drug delivery reviews, 177, 113925. https://doi.org/10.1016/j.addr.2021.113925
MLA
Maher, Sam, et al. "Formulation strategies to improve the efficacy of intestinal permeation enhancers.." Advanced drug delivery reviews, 2021. https://doi.org/10.1016/j.addr.2021.113925
RethinkPeptides
RethinkPeptides Research Database. "Formulation strategies to improve the efficacy of intestinal..." RPEP-05577. Retrieved from https://rethinkpeptides.com/research/maher-2021-formulation-strategies-to-improve
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.